Publications by Center Staff

The Cortical Signature of Prodromal AD: Regional Thinning Predicts Mild AD Dementia
2009

Bakkour A, Morris JC and Dickerson BC (2009). The cortical signature of prodromal AD:  Regional thinning predicts mild AD dementia. Neurology; 72: 1048-1055. PMC Journal-In Process.

The Effects of Amyloid Precursor Protein on Postsynaptic Composition and Activity
2009

Hoe HS, Fu Z, Makarova A, Lee JY, Lu C, Feng L, Pajoohesh-Ganji A, Matsuoka Y, Hyman BT, Ehlers MD, Vicini S, Pak DT and Rebeck GW (2009). The effects of amyloid precursor protein on postsynaptic composition and activity. J Biol Chem; 284:  8495-8506.

The Episodic Memory System: Circuits and Disorders
2009

Dickerson BC and Eichenbaum H (2009). The episodic memory system:  Circuits and disorders. Neuropsychopharmacology. Epub Ahead of Print.

The Overlap of Depression and Delirium in Older Hospitalized Patients
2009

Givens JL, Jones RN and Inouye SK (2009).  The overlap of depression and delirium in older hospitalized patients.  J Am Geriatr Soc; 57:  1347-1353. PMCID:  2728175.

The Rationale and Design of the Antihypertensives and Vascular, Endothelial, and Cognitive Function (AVEC) Trial in Elderly Hypertensives with Early Cognitive Impairment: Role of the Main Angiotensin System Disinhibition
2009

Hajjar I, Hart M, Milberg W, Novak V and Lipsitz L (2009). The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment:  Role of the renin angiotensin system inhibition. BMC Geriatrics; 9: 48. November 18. Epub Ahead of Print.

Tyrosine and Serine Phosphorylation of Alpha-Synuclein Have Opposing Effects on Neurotoxicity and Soluble oligomer Formation
2009

Chen L, Periquet M, Wang X, Negro A, McLean PJ, Hyman BT and Feany MB (2009). Tyrosine and serine phosphorylation of alpha-synuclein have opposing effects on neurotoxicity and soluble oligomer formation. J Clin Invest; 119:  3257-3265. PMCID:  2769182.

Vascular Risk Factors and Dementia: How to Move Forward?
2009

Viswanathan A, Rocca W and Tzourio C. (2009). Vascular risk factors and dementia:  How to move forward? Neurology; 72: 368-374. PMCID:  2677504.

Vaseoreactivity and Peri-Infarct Hyperintensities in Stroke
2009

Zhao P, Alsop D, AbdulJalil A, Selim M, Lipsitz L, Novak P, Caplan L, Hu K and Novak V (2009). Vaseoreactivity and peri-infarct hyperintensities in stroke. Neurology; 72: 643-649. PMCID:  2677535.

Atrophy Accelerates with Conversion From Mild Cognitive Impairment to Alzheimer's Disease (Invited Editorial)
2008

Mueller SG and Dickerson BC (2008). Atrophy accelerates with conversion from mild cognitive impairment to Alzheimer's disease (invited editorial). Neurology; 70:  1728-1729. PMC Journal-In Process

A Genomic Scan for Age at Onset of Alzheimer's Disease in 437 Families from the NIMH Genetic Initiative
2008

Dickson MR, Li J, Wiener HW, Perry RT, Blacker D, Bassett SS and Go RC (2008). A genomic scan for age at onset of alzheimer's disease in 437 families from the nimh genetic initiative. Am J Med Genet B Neuropsychiatr Genet; 147:  784-792.